| abstract |
Among others, the present invention relates to technologies for efficient and effective identification of ETaG, for example, from fungal genomes. In some embodiments, the technologies of the invention are particularly useful for identifying mammalian targets of fungi biosynthetic products. In some embodiments, the technologies of the invention are particularly useful for identifying and / or prioritizing human targets for drug development. In some embodiments, the technologies of the invention are particularly useful for developing modulators for human targets based on fungi biosynthetic products. |